CVR: 29178291
Secondary names: PHARMAORIGIN.COM ApS
Previous names: ApS KBUS 17 NR. 4503
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udvikle lægemidler samt dermed beslægtede aktiviteter.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | 100 t. | 1.5 mio. | 1.5 mio. | 0 | |
| 2024 | - | 94 t. | 1.4 mio. | 1.4 mio. | - | |
| 2023 | - | 87 t. | 1.3 mio. | 1.3 mio. | - | |
| 2022 | - | 47 t. | 1.2 mio. | 1.2 mio. | - | |
| 2021 | - | 40 t. | 1.2 mio. | 1.1 mio. | - | |
| 2020 | - | 13 t. | 1.1 mio. | 1.1 mio. | - | |
| 2019 | - | 18 t. | 1.1 mio. | 1.1 mio. | 0 | |
| 2018 | - | -23 t. | 1.1 mio. | 1.1 mio. | - | |
| 2017 | - | -4.3 mio. | 1.1 mio. | 1.1 mio. | - | |
| 2016 | - | -1.7 mio. | 5.4 mio. | 5.4 mio. | - | |
| 2015 | - | -135 t. | 7 mio. | 4.2 mio. | - | |
| 2014 | - | -558 t. | 5.6 mio. | 4.3 mio. | - | |
| 2013 | 0 | -938 t. | 5.3 mio. | -132 t. | - | |
| 2012 | - | -149 t. | 4.9 mio. | 806 t. | - |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 290 companies in Drift af sundhedsvæsen i øvrigt i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
PHARMAORIGIN ApS has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 100,000.
As of June 17, 2026, Danielle Marie Brown is registered as director of PHARMAORIGIN ApS.
As of June 17, 2026, David Lee Lowrance has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 94,000.
PHARMAORIGIN ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 87,000.
PHARMAORIGIN ApS has published its annual report for 2022. The net result was DKK 47,000.
PHARMAORIGIN ApS has published its annual report for 2021. The net result was DKK 40,000.
PHARMAORIGIN ApS has published its annual report for 2020. The net result was DKK 13,000.
As of September 11, 2020, Robert Norman Neville has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2019. The net result was DKK 18,000.
PHARMAORIGIN ApS has published its annual report for 2018. The net result was DKK -23,000.
PHARMAORIGIN ApS has published its annual report for 2017. The net result was DKK -4,332,000.
PHARMAORIGIN ApS has published its annual report for 2016. The net result was DKK -1,713,000.
As of June 1, 2017, David Lee Lowrance is registered as director of PHARMAORIGIN ApS.
As of July 15, 2016, Robert Norman Neville is registered as director of PHARMAORIGIN ApS.
As of July 15, 2016, Kim Arvid Nielsen has stepped down as adm. dir. of PHARMAORIGIN ApS.
As of July 15, 2016, Savara ApS is registered as an owner of PHARMAORIGIN ApS with an ownership share of 100%.
PHARMAORIGIN ApS has published its annual report for 2015. The net result was DKK -135,000.
As of January 22, 2016, Søren Bech Justesen has stepped down as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2014. The net result was DKK -558,000.
As of June 1, 2015, Søren Bech Justesen is registered as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -937,714.
As of December 27, 2013, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of PHARMAORIGIN ApS.
As of December 27, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PHARMAORIGIN ApS.
As of October 29, 2013, Kim Arvid Nielsen is registered as adm. dir. of PHARMAORIGIN ApS.
As of October 29, 2013, Henrik Lasse Lindblad has stepped down as adm. dir. of PHARMAORIGIN ApS.
PHARMAORIGIN ApS has published its annual report for 2012. The net result was DKK -149,195.
As of June 21, 2012, Lars Heslet has left the board of directors of PHARMAORIGIN ApS.
As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of PHARMAORIGIN ApS.
As of October 19, 2011, Henrik Lasse Lindblad is registered as adm. dir. of PHARMAORIGIN ApS.
As of October 19, 2011, Lars Heslet has stepped down as director of PHARMAORIGIN ApS.
As of August 31, 2011, Kaare Fiala has left the board of directors of PHARMAORIGIN ApS.
As of August 31, 2011, Kaare Fiala has stepped down as adm. dir. of PHARMAORIGIN ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMAORIGIN ApS.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of PHARMAORIGIN ApS.
As of April 12, 2011, Peter Høngård Andersen has left the board of directors of PHARMAORIGIN ApS.
As of April 12, 2011, Leif Helth Jensen has left the board of directors of PHARMAORIGIN ApS.
As of January 1, 2008, Peter Høngård Andersen has joined the board of directors of PHARMAORIGIN ApS.
As of November 30, 2007, A/S PSE NR. 4820 has been appointed auditor of PHARMAORIGIN ApS.
As of November 30, 2007, DKNF 387 ApS has stepped down as auditor of PHARMAORIGIN ApS.
As of November 29, 2007, Lars Heslet has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Leif Helth Jensen has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Eric Jean Marie Leire has joined the board of directors of PHARMAORIGIN ApS.
As of November 29, 2007, Kaare Fiala has joined the board of directors of PHARMAORIGIN ApS.
As of December 12, 2006, Tom Glæsner Larsen has stepped down as director of PHARMAORIGIN ApS.
As of October 1, 2006, Kaare Fiala is registered as adm. dir. of PHARMAORIGIN ApS.
As of December 2, 2005, Lars Heslet is registered as director of PHARMAORIGIN ApS.
As of November 23, 2005, DKNF 387 ApS has been appointed auditor of PHARMAORIGIN ApS.
As of November 23, 2005, JUT NR. 2180 A/S has stepped down as auditor of PHARMAORIGIN ApS.
As of November 23, 2005, Tom Glæsner Larsen is registered as director of PHARMAORIGIN ApS.
As of November 23, 2005, Peter Andreas Stakemann has stepped down as director of PHARMAORIGIN ApS.
On November 23, 2005, the company changed its name from ApS KBUS 17 NR. 4503 to PHARMAORIGIN ApS.
As of November 14, 2005, JUT NR. 2180 A/S has been appointed auditor of PHARMAORIGIN ApS.
As of November 14, 2005, Peter Andreas Stakemann is registered as director of PHARMAORIGIN ApS.
PHARMAORIGIN ApS was founded on November 14, 2005.
Companies in the same industry and area
CVR 32919022
CVR 38900137
CVR 45591743
CVR 41514671
CVR 45819736
companydata.dk